Kiora Pharmaceuticals
Latest round
- Series D
Last raised
- Dec 2009
Total raised
- $34M
Investors
- 5
About Kiora Pharmaceuticals
Based in Massachusetts, US, and founded in 1998 by Franz Obermayr (CEO), and VP Brenda Mann, Eyegate Pharmaceuticals Inc doing business as Kiora Pharmaceuticals, Inc. operates as a pharmaceutical company that develops medicine to treat eye diseases. Kiora Pharmaceuticals, Inc. develops EGP-437 a reformulated topically active corticosteroid, Dexamethasone Phosphate that is delivered into the ocular tissues through a drug delivery system, the EyeGate II Delivery System. It develops EGP-437 for the treatment of various inflammatory conditions of the eye, including the treatment of ocular inflammation and pain in post-surgical cataract patients and uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and ciliary body. Eyegate Pharmaceuticals Inc plans to expand its operations such as clinical trials, working capital, and other general corporate purposes.
Who invested in Kiora Pharmaceuticals
5 investors across 4 rounds
See all investors in Kiora Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kiora Pharmaceuticals
Who invested in Kiora Pharmaceuticals?
Kiora Pharmaceuticals has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kiora Pharmaceuticals raised?
Kiora Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Kiora Pharmaceuticals last raise money?
Kiora Pharmaceuticals's most recent round on record is a Series D, in Dec 2009.
What does Kiora Pharmaceuticals do?
Based in Massachusetts, US, and founded in 1998 by Franz Obermayr (CEO), and VP Brenda Mann, Eyegate Pharmaceuticals Inc doing business as Kiora Pharmaceuticals, Inc.
Where is Kiora Pharmaceuticals headquartered?
Kiora Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Kiora Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Kiora Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Kiora Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.